|
|
|
|
|
|
by noname123
3899 days ago
|
|
|
They have a collaboration with the Broad where they want to run their analysis pipeline on Google's compute cluster. https://cloud.google.com/genomics/gatk?hl=en They also have a project with Novartis (I think not with NIBR however) to do glucose testing via contact lenses. http://www.reuters.com/article/2015/09/05/us-novartis-ceo-id... If I have to guess, I don't think Google plan to build a HTS facility for drugs R&D or a huge lab foot-print to do wet-lab work. They probably want to leverage their existing compute/engineering infrastructure to get involved in the next phase of informatics needs in health care and life science (e.g., cloud storage and compute needs for clinical genome sequencing, analysis workflows like 23andMe for academia/industry/clinical). |
|
|